Links Between N6-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
Yundi Zhang,Ke Zhang,Haoming Gong,Qin Li,Lajie Man,Qingchang Jin,Lin Zhang,Song Li
DOI: https://doi.org/10.3389/fcell.2022.807129
IF: 5.5
2022-02-10
Frontiers in Cell and Developmental Biology
Abstract:N 6 -methyladenosine (m 6 A) is a critical epigenetic modification for tumor malignancies, but its role in regulating the tumor microenvironments (TMEs) has not been fully studied. By integrating multiple data sets and multi-omics data, we comprehensively evaluated the m 6 A “writers,” “erasers,” and “readers” in colorectal cancer and their association with TME characteristics. The m 6 A regulator genes showed specific patterns in co-mutation, copy number variation, and expression. Based on the transcriptomic data of the m 6 A regulators and their correlated genes, two types of subtyping systems, m 6 A reg Cluster and m 6 A sig Cluster, were developed. The clusters were distinct in pathways (metabolism/inflammation/extracellular matrix and interaction), immune phenotypes (immune-excluded/immune-inflamed/immune-suppressive), TME cell composition (lack immune and stromal cells/activated immune cells/stromal and immune-suppressive cells), stroma activities, and survival outcomes. We also established an m 6 Ascore associated with molecular subgroups, microsatellite instability, DNA repair status, mutation burdens, and survival and predicted immunotherapy outcomes. In conclusion, our work revealed a close association between m 6 A modification and TME formation. Evaluating m 6 A in cancer has helped us comprehend the TME status, and targeting m 6 A in tumor cells might help modulate the TME and improve tumor therapy and immunotherapy.
cell biology,developmental biology